Avoidance of CYP2D6 inhibitors in patients receiving tamoxifen
- PMID: 20823421
- DOI: 10.1200/JCO.2010.30.1887
Avoidance of CYP2D6 inhibitors in patients receiving tamoxifen
Comment on
-
Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer.J Clin Oncol. 2010 May 10;28(14):2423-9. doi: 10.1200/JCO.2009.25.0894. Epub 2010 Apr 12. J Clin Oncol. 2010. PMID: 20385997
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
